As innovative therapies for complex and chronic conditions continue to expand, employers and plan sponsors are under growing pressure to manage specialty drug costs while ensuring patients receive the care they need. In one Carelon leadership article, experts outline three core strategies to strengthen specialty pharmacy care, recognizing that “...specialty drugs often come at a high cost, and patients with diseases such as cancer, Crohn's disease, and multiple sclerosis (MS) who rely on these medications shouldn't have to struggle to access them.”
Carelon first underscores the critical role of driving affordability, recommending focused clinical utilization management and close monitoring of emerging biosimilars that can provide more cost-effective alternatives. The organization also highlights the importance of improving accessibility, encouraging the use of digital engagement tools, trained care navigators, and 24/7 support to guide members through the complexities of their treatment journey. Finally, Carelon calls for greater collaboration across the healthcare ecosystem, emphasizing that coordinated partnerships are essential to advancing whole-health outcomes for individuals who rely on specialty medications.
Together, these strategies reinforce a patient-centered approach aimed at delivering meaningful, sustainable improvements in specialty pharmacy care. Read the full article on Carelon.com to learn more about this vision.
You may also be interested in:
Help members save on prescriptions
Pipeline to prescription: CarelonRx formulary development
Plan for and manage your specialty spend
